The invention relates to neuroactive peptides or analogues thereof, having at
least one of the biological activities of angiotensin IV, and which comprise the
sequence Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe, to methods of modulating neuronal
activity, and to pharmaceutical composition thereof.